Clinical trial
Efficacy of Pregnenolone in Patients With Schizophrenia
NCT00615511 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Pregnenolone in Patients With Schizophrenia
- Lead sponsor
- Weill Medical College of Cornell University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2007
- Completion date
- December 31, 2014
- Enrollment
- 100 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
schizoaffective disorder, schizophrenia
Lead sponsor's other trials
Weill Medical College of Cornell University, most recent start first.
+886 more trials
Similar trials
Same condition (Psychotic Disorders) and phase, most recent start first.
+121 more trials See the condition page